Literature DB >> 12355368

Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro.

Tzou-Yien Lin1, Chishih Chu, Cheng-Hsun Chiu.   

Abstract

Enterovirus 71 (EV71), the newest member of Enterovirudae, is notable for its etiological role in epidemics of severe neurological diseases in children. It appears to be emerging as an important virulent neurotropic enterovirus in the upcoming era of poliomyelitis eradication, whereas no effective vaccine or antiviral agents are available at this moment. Human and bovine lactoferrins, iron-binding proteins belonging to the nonimmune defense system, were assayed in vitro to assess their inhibiting capacity on the cytopathic effect of EV71 on human embryonal rhabdomyosarcoma (RD) cells. Both bovine and human lactoferrins were found to be potent inhibitors of EV71 infection (mean IC(50), 10.5-24.5 microg/mL and 103.3-185.0 microg/mL, respectively). Lactoferrin probably exerts its effect at the level of viral adsorption, since the ongoing infection could not be further inhibited after the EV71 penetrated RD cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355368     DOI: 10.1086/343809

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Cell surface nucleolin facilitates enterovirus 71 binding and infection.

Authors:  Pei-Yi Su; Ya-Fang Wang; Sheng-Wen Huang; Yu-Chih Lo; Ya-Hui Wang; Shang-Rung Wu; Dar-Bin Shieh; Shun-Hua Chen; Jen-Ren Wang; Ming-Der Lai; Chuan-Fa Chang
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

2.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 3.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads.

Authors:  Yu-Wen Lin; Kung-Chao Chang; Chia-Min Kao; Shih-Ping Chang; Yuk-Ying Tung; Shun-Hua Chen
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

6.  Factors associated with fatal outcome of children with enterovirus A71 infection: a case series.

Authors:  S D Yang; P Q Li; Y G Huang; W Li; L Z Ma; L Wu; N Wang; J M Lu; W Q Chen; Guang-Ming Liu; Y M Xiong; Y L Chen; Ying Zhang
Journal:  Epidemiol Infect       Date:  2018-03-12       Impact factor: 4.434

7.  Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells.

Authors:  Pei-Yi Su; Yueh-Tung Liu; Hsin-Yueh Chang; Sheng-Wen Huang; Ya-Fang Wang; Chun-Keung Yu; Jen-Ren Wang; Chuan-Fa Chang
Journal:  BMC Microbiol       Date:  2012-08-01       Impact factor: 3.605

8.  Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.

Authors:  Esmail M El-Fakharany; Lourdes Sánchez; Hussein A Al-Mehdar; Elrashdy M Redwan
Journal:  Virol J       Date:  2013-06-19       Impact factor: 4.099

9.  Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.

Authors:  Chee Wah Tan; Yoke Fun Chan; Kooi Mow Sim; Eng Lee Tan; Chit Laa Poh
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

Review 10.  Recent developments in antiviral agents against enterovirus 71 infection.

Authors:  Chee Wah Tan; Jeffrey Kam Fatt Lai; I-Ching Sam; Yoke Fun Chan
Journal:  J Biomed Sci       Date:  2014-02-12       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.